Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Blue Pool Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 24
Average round size
info
The average size of a deal this fund participated in
$197M
Portfolio companies 20
Rounds per year 1.20
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Exits 4
Key employees 5
Stages of investment
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Life Science
  • Retail

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Blue Pool Capital:
Typical Co-investors
Blue Pool Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Blue Pool Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Ai Hexin Touzi China, Liaoning, Shenyang
Beijing Huadian Shidai Technology Development Beijing, Beijing, China
Beijing Zhiyun Asset Management Beijing, Beijing Shi, China
China Reinsurance Group Beijing, Beijing, China
Hangzhou Yongyuan China, Hangzhou, Zhejiang
LSP BioVentures Cambridge, Massachusetts, United States
MGM Studios Beverly Hills, California, United States
RoseRock Bryan, Texas, United States
The MasterCard Foundation Canada, Ontario, Toronto
Tibet Kexin Venture Investment Partnership (L.P.) Chengguan District, China, Lhasa

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Cambium Carbon

Environmental Consulting
Professional Services
$5M30 Nov 2023 New York, New York, United States

Artifact Labs

Blockchain
$3M08 May 2023 Hong Kong, Hong Kong, China

Opal Wearables

Consumer Electronics
Internet of Things
Wearables
04 May 2023 New York, New York, United States

LifeMine Therapeutics

Biotechnology
Life Science
Therapeutics
$175M23 Mar 2022 Cambridge, Massachusetts, United States

Aver

Blockchain
Cryptocurrency
$7M24 Jan 2022 -

Artemis

$2M10 Dec 2021 -

The Sandbox

Blockchain
Cryptocurrency
Online Games
Trading Platform
Video Games
$93M02 Nov 2021 San Francisco, California, United States

Fog Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$107M11 Jan 2021 Cambridge, Massachusetts, United States

LifeMine Therapeutics

Biotechnology
Life Science
Therapeutics
$50M07 Jan 2021 Cambridge, Massachusetts, United States
News
NEX raises $25M, launches Active Arcade to get people moving

– NEX, a motion entertainment startup, raised $25m funding.
– The round was led by Blue Pool Capital and joined by Samsung Ventures, SparkLabs and Susquehanna.
– It brings NEX to a valuation of $100m.
– The company is building motion entertainment – content that encourages physical movement.

FogPharma® Announces $107 Million Series C Financing to Advance Direct β-Catenin Antagonist and Universal Druggability™ Platform

– FogPharma announced the completion of a $107m Series C financing round.
– The round was led by venBio Partners with participation from new investors Cormorant Asset Management, Farallon Capital Management, Invus, funds and accounts advised by T. Rowe Price Associates, Inc.; HBM Healthcare Investments, Casdin Capital, and PagsGroup.
– Existing investors, including GV, 6 Dimensions Capital, Deerfield Management and Blue Pool Capital also participated in the oversubscribed round.
– FogPharma’s proprietary hyperstabilized α-helical peptides (Helicon™ peptides) are a new class of therapeutics that combine the targeting strength and specificity of antibodies with the broad tissue distribution, intracellular target engagement and oral dosing optionality of small molecules.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Blue Pool Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 24
Average round size 197M
Rounds per year 1.20
Peak activity year 2018
Lead investments 3
Follow on index 0.17
Exits 4
Group Appearance index 0.96

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Cambium Carbon

Environmental Consulting
Professional Services
$5M30 Nov 2023 New York, New York, United States

Artifact Labs

Blockchain
$3M08 May 2023 Hong Kong, Hong Kong, China

Opal Wearables

Consumer Electronics
Internet of Things
Wearables
04 May 2023 New York, New York, United States

LifeMine Therapeutics

Biotechnology
Life Science
Therapeutics
$175M23 Mar 2022 Cambridge, Massachusetts, United States

Aver

Blockchain
Cryptocurrency
$7M24 Jan 2022 -

Artemis

$2M10 Dec 2021 -

The Sandbox

Blockchain
Cryptocurrency
Online Games
Trading Platform
Video Games
$93M02 Nov 2021 San Francisco, California, United States

Fog Pharmaceuticals

Biotechnology
Health Care
Pharmaceutical
$107M11 Jan 2021 Cambridge, Massachusetts, United States

LifeMine Therapeutics

Biotechnology
Life Science
Therapeutics
$50M07 Jan 2021 Cambridge, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: